Physician

Khaled Hammadi Janom, M.D.

According to 2025 Medicare claims, Khaled Janom, M.D. (NPI: 1528592128) practices internal medicine in the Twin Falls, ID market, with the plurality of this provider's patient population coming from Twin Falls, ID. This provider's primary affiliated billing organization is IDAHO KIDNEY INSTITUTE LLP (NPI: 1013064690; TIN: 202388521) and primary practice location at 83202-4707. Janom is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), and Aledade 151 Northern Territories MSSP Enhanced (ACO ID: A5349), participating under the MSSP model.

Janom's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 1,412 HCPCS/CPT codes, and received $149,981 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,428 prescription claims across 248 beneficiaries totaling $228,988 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 156 claims. Open Payments data shows 11 records totaling $177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,418 to $228,988. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	97	201	$19,925
2023	212	798	$99,485
2024	294	1,412	$149,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	34	$3,418
2018	43	242	$19,342
2019	42	259	$20,102
2020	41	186	$29,713
2021	26	65	$16,888
2022	62	188	$12,479
2023	174	794	$71,644
2024	248	1,428	$228,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	156	$2,825

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	38	223	$260
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	24	58	$215
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	63	66	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	344	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	40	63	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	29	1,042	$85,624
Auryxia	Ferric Citrate	16	1,020	$28,243
Lanthanum Carbonate	Lanthanum Carbonate	15	930	$18,853
Sevelamer Carbonate	Sevelamer Carbonate	70	4,255	$13,454
Clinisol	Parenteral Amino Acid 15% No.5	47	329	$5,683

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	14	$874
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	48	$589
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$565
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	19	$405
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	32	$383

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$177	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Khaled Hammadi Janom, M.D.?

Tedicare shows public-source Medicare data for Khaled Hammadi Janom, M.D. (NPI 1528592128), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khaled Hammadi Janom, M.D. have ACO affiliation data?

Khaled Hammadi Janom, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), and Aledade 151 Northern Territories MSSP Enhanced (MSSP, ACO ID A5349).

What billing organization is linked to Khaled Hammadi Janom, M.D.?

Khaled Hammadi Janom, M.D. is linked to IDAHO KIDNEY INSTITUTE LLP (billing NPI 1013064690) in the available physician profile data.

Does Khaled Hammadi Janom, M.D. have Open Payments data?

Khaled Hammadi Janom, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.